




Methodological Considerations for Studies in Sport and Exercise 
Science with Women as Participants: A Working Guide for Standards 
of Practice for Research on Women
Kirsty J. Elliott‑Sale1  · Clare L. Minahan2  · Xanne A. K. Janse de Jonge3  · Kathryn E. Ackerman4  · 
Sarianna Sipilä5  · Naama W. Constantini6  · Constance M. Lebrun7  · Anthony C. Hackney8 
Accepted: 6 February 2021 
© The Author(s) 2021
Abstract
Until recently, there has been less demand for and interest in female-specific sport and exercise science data. As a result, 
the vast majority of high-quality sport and exercise science data have been derived from studies with men as participants, 
which reduces the application of these data due to the known physiological differences between the sexes, specifically with 
regard to reproductive endocrinology. Furthermore, a shortage of specialist knowledge on female physiology in the sport 
science community, coupled with a reluctance to effectively adapt experimental designs to incorporate female-specific con-
siderations, such as the menstrual cycle, hormonal contraceptive use, pregnancy and the menopause, has slowed the pursuit 
of knowledge in this field of research. In addition, a lack of agreement on the terminology and methodological approaches 
(i.e., gold-standard techniques) used within this research area has further hindered the ability of researchers to adequately 
develop evidenced-based guidelines for female exercisers. The purpose of this paper was to highlight the specific considera-
tions needed when employing women (i.e., from athletes to non-athletes) as participants in sport and exercise science-based 
research. These considerations relate to participant selection criteria and adaptations for experimental design and address 
the diversity and complexities associated with female reproductive endocrinology across the lifespan. This statement intends 
to promote an increase in the inclusion of women as participants in studies related to sport and exercise science and an 
enhanced execution of these studies resulting in more high-quality female-specific data.
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Key Points 
Not all ‘women’ are the same. Women have a variety of 
reproductive hormonal profiles that change across the 
lifespan from puberty to the menopause.
The endogenous hormonal profile of women is fre-
quently influenced by exogenous sources, such as 
hormonal contraceptives (HC) and hormone replacement 
therapy (HRT).
Depending on the research question, women should be 
recruited on pre-defined, standardised criteria, which, 
in most cases, should be retrospectively confirmed (i.e., 
homogenous a priori inclusion and a posteriori exclusion 
criteria).
Depending on the research question, the experimental 
design needs to be adapted in line with the hormonal 
milieu (e.g., consideration of menstrual cycle phase, type 
of HC used, stage of menopause).
1 Introduction
1.1  Statement of the Problem
Across the lifespan, circulating concentrations of oestrogen 
and progesterone change from puberty, through adulthood, 
until menopause, when a dramatic decline in the secretion 
of ovarian steroids occurs and cyclic oestrogen production 
is replaced by a low constant production by the ovaries. 
Furthermore, between puberty and menopause, circulating 
concentrations of oestrogen fluctuate fivefold and proges-
terone greater than 50-fold over a 21- to 35-day cycle (i.e., 
menstrual cycle). Indeed, these cyclical acute fluctuations 
in ovarian hormones across the menstrual cycle may be 
altered by external factors (e.g., hormonal contraceptives 
[HC], circadian variation, diet, exercise), clinical conditions 
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(e.g., functional hypothalamic amenorrhea, polycystic ovary 
syndrome) and pregnancy (Fig. 1; [1]).
In addition to reproductive function, ovarian steroids have 
been shown to target a number of tissues (e.g., epithelial, 
connective, muscle and nervous; [2–4]) and influence an 
array of biological processes (e.g., metabolism, ventilation, 
immunity, cognition, gastrointestinal, cardiovascular, auto-
nomic regulation, and genitourinary function; [5–13]). As 
such, different concentrations of circulating ovarian steroids 
throughout the lifespan and across the menstrual cycle (with 
and without dysfunction and/or manipulation) might sig-
nificantly influence the mechanisms that control and regu-
late cell function and integrated physiologic adaptation in 
women.
Given the potential influence of ovarian hormones on 
multiple biological systems, it is reasonable to assume that 
the heterogeneic findings observed among studies conducted 
with women as participants, particularly those examining 
physiological responses to exercise and adaptations to 
training, may be attributable to the numerous hormonal 
profiles a woman may experience during her lifetime. As 
such, it is important that scientists consider the potential 
effects of ovarian hormones throughout the lifespan on 
exercise responses and sports performance and apply suit-
able methodology to their studies in order to control these 
effects and reduce the heterogeneic results. Nonetheless, for 
decades scientists have avoided conducting sport and exer-
cise research with women as participants due, in part, to 
the complex methodological considerations required and/or 
the difficulty in interpreting the heterogeneic results often 
observed within and among studies. Consequently, research 
findings from sport and exercise performance and training 
studies with men only as participants are applied to women, 
which can result in a missed opportunity for women to reach 
their athletic and performance potential. In order to guide 
scientists and practitioners through the complexities of: i. 
identifying the maturation status and menstrual-cycle status 
of women participants, and ii. designing studies that provide 
insight into the difference in the physiological responses to 
exercise among the various hormonal profiles of women, 
guidance on the definition(s) of sampled populations is 
required and a working guide for standards of practice for 
research in this field is warranted.
1.2  Current State of the Art
Research into the effects of the menstrual cycle on the exer-
cise response has being ongoing since at least 1876, when 
Professor Mary Jacobi won the Harvard University Boylston 
Prize Essay for her observations on menstruation and physi-
cal work and rest [14]. Despite a recent growing interest 
in research in sport and exercise science with women as 
participants, the overall research quantity in this area is still 
very small compared to research with men as participants 
[15]. Therefore, the effects of oestrogen and progesterone 
on women’s responses to exercise and adaptations to train-
ing are still not fully understood. As a result, there are no 
sport and exercise-related guidelines for training and nutri-
tion which are customised for sportswomen (i.e., athletes 
and exercisers) and underpinned by sufficient, high-quality 
scientific evidence. Numerous reviews [e.g., 16–20], books 
Fig. 1  Indicative oestrogen and progesterone profiles across the lifes-
pan from childhood to senescence: a oestrogen (pmol∙L−1). With 
regards to oestrogen, the menstrual cycle has 20 times more oestro-
gen than pre-puberty and pregnancy 35 times more oestrogen than the 
menstrual cycle; b progesterone (nmol∙L−1). The menstrual cycle has 
35 times more progesterone than pre-puberty and pregnancy almost 7 
times more progesterone than during the menstrual cycle. Oral con-
traceptives users and post-menopausal women have similar levels 
of endogenous oestrogen and progesterone. Hypothalamic-pituitary 
forms of amenorrhea (not depicted here) do not show any evidence of 
oestrogen production based on urinary measurements [1]. In women, 
“oestrogen” includes the oestrone, oestradiol, oestriol hormones
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[e.g., 21–23] and meta-analyses [e.g., 24,25] have summa-
rised and examined data from this field spanning almost 
50 years, but all have concluded that more, better quality 
studies are needed before a consensus on the effects of ovar-
ian steroids on training and performance can be reached.
It is clear that more research focusing on areas unique 
to female physiology is required to inform best practice 
guidelines for training and nutrition [24, 25]. There are 
some studies, however, that have demonstrated clear and 
recurring findings of ovarian-steroid interference with 
biological processes that may affect athletic performance 
(i.e., responses to exercise and adaptation to, and recovery 
from, training), which highlight the importance of consid-
ering ovarian steroid profiles in sport and exercise science 
research. In particular, the manipulation of endogenous 
ovarian steroid levels with synthetic hormones (i.e., HC) has 
been repeatedly associated with increased markers of muscle 
damage in women after unaccustomed eccentric exercise [8, 
26–30]. Therefore, knowledge of the use of HC by athletes 
or research participants is imperative in understanding the 
recovery process after an acute bout of exercise or adaptation 
to training. There is a strong body of evidence indicating 
altered thermoregulation in women taking HC during exer-
cise including altered skin blood flow and cutaneous vaso-
dilation, as well as a delayed onset of sweating and a higher 
internal temperature threshold [31–35]. As such, ovarian 
hormone interference via the administration of HC may 
have implications for exercise in the heat. Oestrogen is often 
associated with substrate oxidation and utilisation during 
prolonged exercise. The notion that elevated plasma oestro-
gen concentrations increase the reliance on fat as an energy 
source during endurance exercise is a consistent observation 
[6, 36–38]. Despite these few convincing findings, whether 
disturbances to these physiological mechanisms result in a 
decrement to performance in strength, speed, and/or endur-
ance events remains to be elucidated. It should be also noted 
that there is always at least one study that opposes the find-
ings of the majority and as newer formulations of synthetic 
hormones are developed, there will be further ambiguity 
in the findings. Therefore, the importance of considering 
a woman’s current ovarian hormonal profile in sport and 
exercise science research is paramount.
1.3  The Gap in the Field
Rather than viewing the dynamic profiles of ovarian ster-
oids in women as a reason to exclude them from sport and 
exercise science research, future studies need to explore the 
specific effects of oestrogen and progesterone and related 
hormonal ageing on physiological function and ergo athletic 
performance across the lifespan in women. Female-specific 
research is needed as the number of women participating 
in sport and exercise is increasing in many countries, and 
parity in the Olympics and Paralympics is approaching (i.e., 
equal number of male and female competitors and medals). 
For example, in 1900 only 2.2% of the competitors in the 
Olympics were female; in 1952 the proportion was 10.5%, 
in 2000 it was 38.2% and in 2021 it is predicted to be 48.8%. 
If male-based research continues to be applied to females, 
there is a risk that the true potential of women will not be 
achieved as the potential influence of ovarian hormones 
remains unclear; herein exist the gap in the field and the 
fundamental statement of the problem within contemporary 
sport and exercise science. At the elite level, understanding 
the effects of oestrogen and progesterone on body systems 
and performance may produce the marginal gain needed for 
success. In addition, there is a need to understand the effects 
of training on hypothalamic, pituitary and ovarian hormones 
and related outcomes, such as body composition and bone 
[39]. At the recreational level, understanding the impact of 
changes in ovarian hormone concentration, experienced dur-
ing the menstrual cycle or as a result of menstrual irregulari-
ties, hormonal contraceptive use, pregnancy or the meno-
pause, on the ability and willingness to undertake exercise 
and physical activity may help reduce the disproportionate 
decline in sports participation seen at puberty in girls [40, 
41]. This decrease in physical activity often extends into 
adulthood, and is compounded during pregnancy and the 
postpartum period [22], and as such has implications for 
health and well-being [42] for women of all ages. Among 
middle-aged women, menopausal hormonal changes are 
associated with deterioration of the body systems [43], per-
formance and functioning [44], but further understanding is 
needed of the magnitude and timing of these changes as well 
as the role of physical activity and exercise to overcome or 
attenuate these changes.
In order to facilitate a new generation of quality 
research in sport and exercise science with women as 
participants that addresses the current gap in the field, 
direction is needed on the best and most accurate types 
of research design to employ in this field. In addition, 
guidance on the definition(s) of sampled populations is 
required in order to improve the uniformity of studies 
involving women. As such, this article is intended to serve 
as a working guide for standards of practice for research 
on women.
Synchronous with changes in performance, ovarian ster-
oids exert many clinical effects, which have also received 
less attention in sport and exercise medicine-based research. 
Examples include hyponatremia, which is more prevalent 
in females than males [45] and heat stroke, which is influ-
enced by ovarian hormonal concentrations [46]. Although 
this paper is focused on studies related to sport and exercise 
science, some of the approaches described herein may be 
also relevant for female-based sport and exercise medicine-
based research.
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1.4  Background to the Statement
In the early 2000s, articles started to provide critical commen-
tary on the methodological approach used in studies investi-
gating the effects of oestrogen and progesterone on different 
aspects of exercise performance [18, 47]. This began to raise 
an awareness of some of the technical flaws and issues within 
this field. Cable and Elliott [47] focussed on the methodologi-
cal approach used in studies investigating the effects of ovar-
ian steroids on muscle strength in women. They identified 
inconsistencies in terminology and research design, namely 
differences in the definition of reproductive status (e.g., incon-
sistencies in menstrual cycle phase definition), often leading to 
the grouping of non-homogeneous participants; and quantifi-
cation of reproductive status, by using inaccurate and subjec-
tive methods. In addition, they highlighted that consideration 
needed to be given to characteristics of the hormonal milieu; 
such as, if the changes in ovarian steroids were acute (e.g., 
menstrual cycle) or chronic (e.g., menopause); within normal 
(e.g., menstrual cycle) or supra-physiological (e.g., pregnancy) 
ranges; caused by endogenous fluctuations (e.g., menstrual 
cycle) or exogenous (e.g., HC or hormone replacement therapy 
[HRT]) supplementation. The review by Janse de Jonge [18] 
focussed on methodological considerations in menstrual cycle 
research, including the verification of menstrual cycle phase 
and the timing of testing throughout the cycle. More recently, 
Janse de Jonge et al. [48] consolidated the approaches and 
issues observed specifically in menstrual-cycle studies and pro-
posed methodological guidelines for undertaking menstrual 
cycle-based research in sport and exercise science. Further-
more, broad methodological considerations for studies in exer-
cise endocrinology have been provided lately [49], including 
the critical consideration of sex and the menstrual cycle. The 
current statement builds upon these reviews by providing guid-
ance for studies including women from across the lifespan.
1.5  Approach to the Statement
The considerations outlined herein are based on previous 
research and expert opinion and are delivered alongside the 
rationale and pros and cons for each method. Where appro-
priate the primary source has been provided; however, some 
items have been specifically developed for this statement. 
For ease of reading we are using oestrogen throughout the 
paper, but recognise this encompasses oestradiol, oestrone 
and oestriol. For more detailed information on female endo-
crinology see Hackney [21].
1.6  Purpose of the Statement
The aim of this statement was to consolidate the opin-
ions, lessons and evidence from experienced research-
ers in the area of women’s physiology, with a view to 
providing counsel for those beginning to pursue research 
in this very important area. Moreover, the considerations 
described herein are intended to help dispel the myths and 
poor practices commonly associated with this subject area, 
thus improving the quality of future research and allow-
ing more meaningful comparisons to be made between 
studies that have employed consistent terminology and 
research designs. Overall, this statement aims to contrib-
ute to advancing the scientific community’s knowledge 
and understanding of women’s physiology in the context 
of sport and exercise science.
2  Considerations
2.1  Participants
Much of the heterogeneity in this area of research is 
derived from the lack of uniformity when describing the 
populations used in studies with women as participants. 
While chronological age is often controlled and reported, 
maturation status and menstrual-cycle status (i.e., length, 
irregularities/dysfunction, manipulation) are more often 
not. Moreover, if menstrual-cycle status is even considered 
by researchers, the hormonal profile of the participants is 
often implied rather than confirmed [25] which may exac-
erbate the variability between studies.
In order to overcome these issues, consistency is needed 
in the following: (i) the terminology used to describe par-
ticipants; and (ii) the inclusion/exclusion criteria, spe-
cifically the hormonal parameters, used to define eligi-
ble participants. This uniformity will allow meaningful 
comparison within and among studies (i.e., comparing 
like with like). Table 1 proposes a framework of terms 
and conditions, based on previous research and our col-
lective experience and expertise in the field that could 
help to ensure consistency in women’s sport and exercise-
based studies. Across the lifespan, the ovarian steroids 
start changing at puberty. Therefore, the stage of puberty 
needs to be classified consistently in research with younger 
populations. During the reproductive years there are five 
main factors that will influence the fluctuations in oestro-
gen and progesterone: i) fluctuations across the eumenor-
rheic menstrual cycle; ii) disruptions to the eumenorrheic 
menstrual cycle caused by illness or disease (e.g., polycys-
tic ovary syndrome, endometriosis or other hypothalamic 
pituitary axis disruptions), low energy availability, the first 
two years after menses, and the time nearing menopause; 
iii) manipulation of the eumenorrheic menstrual cycle with 
exogenous hormones, both synthetic and natural (e.g., 
HC and HRT); iv) pregnancy (increasing ovarian steroids 
profile); and v) menopause (decreasing ovarian steroids 
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profile). Researchers should strive to adopt all recommen-
dations that are appropriate, thus facilitating good practice 
in this area.
2.2  Experimental Design
The experimental design employed in studies with women 
as participants is often poorly considered, described, con-
trolled and/or executed, which is mainly due to a lack of 
understanding of the hormonal changes experienced across 
the lifespan in women. In addition, studies involving women 
as participants usually require repeated measures due to the 
acute (e.g., ultradian, circadian and infradian rhythms) and 
chronic fluctuations (e.g., pregnancy, menopause, HC and 
HRT usage) in reproductive hormones over time, unlike in 
studies with men as participants who have relatively stable 
(i.e., outside of circadian variation) sex hormone profiles 
following puberty. Table 2 outlines some methodological 
approaches that could be employed at various stages of the 
life cycle (i.e., puberty, menstrual cycle and irregularities, 
hormonal contraception, pregnancy and menopause) in 
women.
One particular aspect of research design that has contin-
ued to cause debate amongst authors and disparity between 
studies is the nomenclature associated with the phases of the 
menstrual cycle and menopausal status [57]. In the simplest 
terms, the menstrual cycle can be divided into two phases 
that are separated by ovulation; follicular (begins at the onset 
of menses) and luteal (post ovulation). These phases can 
be further divided into the early, mid and late phases for 
each, with or without the inclusion of ovulation as a dis-
crete phase. As such, studies involving eumenorrheic women 
report phases on a continuum from two to seven. Further-
more, the basis for this taxonomy is often unclear; i.e., the 
phases are linked to poorly defined or undefined ovarian 
steroid profiles. Rather than continue to dispute the name of 
menstrual cycle phases, a consensus is needed on the hor-
monal profiles of interest, such that testing timepoints and 
the determination of eligible data can be based on an a priori 
decision. Table 3 and Fig. 4 show four distinct hormonal 
profiles, which represent significant changes in both oes-
trogen and progesterone concentrations. These four profiles 
could be used to investigate the effects of ovarian steroids 
on physiology, health and performance.
2.3  General Guidance
Some methodological issues can affect all sport and exer-
cise science studies with women as participants; these points 
are described in Table 4. One consideration is the use of 
“unclassified” women, viz. where the reproductive profile of 
the participants is not stated. In some studies, it is relevant 
to describe the menstrual characteristics of the participants, 
but not necessary to measure ovarian steroid levels. It is 
important to balance the internal and external validity of 
a study, such that the translational reach and impact of the 
data are not limited. The research design should be suitable 
to answer the research question. For example, if a study is 
designed to examine the effects of menstrual cycle phase on 
an outcome, then biochemical confirmation of the phase is 
warranted alongside self-reported menstrual characteristics 
(e.g., last menses), whereas if a study is designed to examine 
the physical/performance characteristics of a female sports 
team, then a description of the population (i.e., solely self-
reported menstrual cycle phase) may be sufficient. As such, 
the research question should clearly indicate if the intention 
is to attribute an outcome to a specific hormonal profile or 
to observe the characteristics/responses of a clearly defined, 
mixed group of sportswomen or exercisers.
3  Discussion
3.1  Definition of ‘Woman’
Herein cisgender females are described and defined based 
on ovarian steroid concentrations. Transgender females and 
women with differences in sexual development have not 
been characterised but require and deserve further clear 
research parameters to better understand their physiology. 
The diversity in female reproductive endocrinology makes 
it difficult to title and define women based on reproductive 
hormonal profile alone. As such, it can be challenging for 
researchers to decide on the inclusion/exclusion criteria for 
participant recruitment; determine the methods by which 
this criteria can be established; and use the eligibility criteria 
to inform the research design.
• Example 1; a researcher wishing to investigate potential 
effects of the menstrual cycle on exercise performance 
needs to decide: if they will use eumenorrheic or natu-
rally menstruating women (see Table 1 for delineation of 
terminology); how they will confirm eumenorrhea; when 
in the cycle they will test to ensure different hormonal 
environments.
• Example 2; a researcher wishing to use oral contraceptive 
pill (OCP) users will need to decide which role they will 
fulfil (i.e., control or experimental sample [56]):
• OCP users can be used as a control group, wherein cycli-
cal fluctuations in oestrogen and progesterone experi-
enced during the menstrual cycle can be compared to 
consistently downregulated sex hormone levels. The 
researcher then needs to decide whether to compare 
with the active pill phase or the non-active pill phase. 
For example, if the non-active pill phase is compared 
with the early follicular phase, then it is likely that the 
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Fig. 2  Oestrogen reference ranges from three different  sources1,2,3 
for the follicular (F), ovulatory (O) and luteal (L) phases of the men-
strual cycle. All sources are clinical reference ranges from different 
National Health Service Trusts in the UK and are based on the manu-
facturers’ laboratory reference ranges. This figure illustrates the dif-
ferences in the reference ranges for each of the three prevailing oes-
trogen phases of the eumenorrheic menstrual cycle and suggests that 
additional context is required (e.g., blood sample taken on day two 
of bleeding, thus allowing the comparison with the follicular range; 
blood sample taken 12  h after ovulation was denoted by a positive 
urinary luteinising hormone test kit, thus allowing comparison with 
the ovulatory range; blood sample taken seven days after ovulation 
was denoted by a positive urinary luteinising hormone test kit, thus 
allowing comparison with the luteal range values)
Fig. 3  Progesterone reference ranges from three different  sources1,2,3 
for the follicular (F) and luteal (L) phases of the menstrual cycle. All 
sources are clinical reference ranges from different National Health 
Service Trusts in the UK and are based on the manufacturers’ labo-
ratory reference ranges. This figure illustrates the differences in the 
reference ranges for each of the two prevailing progesterone phases 
of the eumenorrheic menstrual cycle and suggests that additional 
context is required (e.g., blood sample taken on day two of bleeding, 
thus allowing the comparison with the follicular range; blood sam-
ple taken seven days after ovulation was denoted by a positive urinary 
luteinising hormone test kit, thus allowing comparison with the luteal 
range values)
Fig. 4  Visual overlay of the hormonal changes across an idealised 
28-day menstrual cycle indicating when each phase begins and ends 
as described in Table 3. The solid gold line represents oestrogen the 
short dash purple line represents luteinising hormone and the long 
dash green line represents progesterone. The black dots represent 
the mean concentration of oestrogen during each phase and the black 
diamonds represent the mean concentration of progesterone in each 
phase
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hormonal environments will be very similar between the 
two groups. If the mid-luteal phase is compared with the 
active pill phase, the hormonal environments between 
groups will be different. The researcher will also need to 
consider the type of OCP being used (i.e., oestrogen and 
progestin formulations and concentrations; monophasic, 
biphasic, triphasic) and the duration of usage, ensuring 
this is similar for the whole control group of OCP users.
• OCP users can also be considered as an experimental 
group, wherein (i) the effects of low endogenous oes-
trogen and progesterone levels can be investigated and/
or (ii) the effects of exogenous oestrogen and proges-
tin can be examined. In this case the researcher needs 
to decide which hormonal environments to compare, 
early in the non-active pill phase (with low endogenous 
and exogenous hormone levels), late in the non-active 
pill phase (with increasing endogenous oestrogen and 
low exogenous hormones), early in the active pill phase 
(with increasing exogenous hormone levels) or late in 
the active pill phase (with highest exogenous hormone 
levels). Again, the researcher will need to consider the 
type of OCP being used and ensure this is similar for 
the whole control group of OCP users and/or consider 
comparison between different types of OCP.
Example 3; a researcher wishing to conduct menopause-
related study needs to decide which menopausal phases to 
include and how to define those phases; whether or not to 
include HRT users or those with ovarian concerns that have 
resulted in hormonal conditions similar to menopause; if 
post-menopausal women are included, how to define the 
time that the participants have been post-menopausal [72].
As such, we propose that:
 (i) sample populations are chosen based on the research 
question;
 (ii) participants are clearly named and described based 
on their reproductive characteristics;
 (iii) hormonal profiles are used to inform the experimen-
tal design.
These steps should help alleviate the ambiguity surround-
ing the classification of women previously seen in sport and 
exercise studies that has led to considerable sampling hetero-
geneity and has hindered meaningful comparison between 
studies.
3.2  Study Validity
The validity of studies, or lack thereof, in sport and exercise 
science using women as participants is rarely discussed. The 
considerations described herein are designed to increase the 
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of stringent recruitment strategies (e.g., using predetermined 
population definitions and strict inclusion/exclusion crite-
ria) and appropriate experimental design (e.g., a priori clas-
sification of hormonal profile associated with each testing 
timepoint and post priori exclusion of data not meeting the 
stipulated terms). These measures should help to ensure that 
the results reflect the truth in the population studied rather 
than methodological errors [73]. At present, given the lack 
of clarity on either the direction or magnitude of potential 
effects of ovarian steroids on physical performance, max-
imising internal validity should be considered a research 
priority. The external validity of studies involving women 
as participants is often more difficult to increase due to the 
large inter and intra-individual variability in ovarian hor-
mone concentrations; by reducing some of this variation 
through precise recruitment and testing, the external valid-
ity is lessened, and thus generalisability is reduced. These 
issues can be somewhat overcome through field-based test-
ing and by testing entire teams, which could help maximise 
the translational potential of performance-based research in 
women.
3.3  Inclusion of Research with Women 
as Participants
Until recently, women were less represented in elite sport. 
Women accounted for only 2.2% of the athletes in the Paris 
Olympics in 1900, but they are predicted to account for an 
estimated high of 48.8% in the next Olympic Games [74]. 
Therefore, the time is right to shift more attention to women 
as participants in sport and exercise science research, espe-
cially given that often the research findings that are based 
on male participants are neither applicable nor generaliz-
able to women. It is not appropriate to exclude women from 
sport and exercise science research for any reason, especially 
on the basis of convenience, i.e. excluding women as par-
ticipants due to the potential confounding effect of female 
hormone fluctuations, or cost, i.e., excluding women as par-
ticipants because they can be more expensive than men to 
study due to the extra time (e.g., repeated measures across 
a menstrual cycle) and resources (e.g., blood samples for 
the determination of ovarian steroid levels) needed to pro-
duce high-quality data. Unfortunately, it is evident that many 
researchers have avoided using female participants with data 
indicating just 4 to 13% of articles from leading journals in 
sports and exercise science included only women as partici-
pants [15]. So even though some research has focussed on 
the effects of ovarian steroids on performance, health and 
physiology, the small quantity of research in this area limits 
our understanding of the topic. Furthermore, the heteroge-
neity in study populations (e.g., eumenorrheic, OCP user, 
post-menopausal) and large variation in research designs 
(e.g., definition of menstrual cycle phase, oral contraceptive 
pill consumption or withdrawal) has resulted in many con-
flicting findings in sport and exercise science research with 
women as participants. To improve our understanding of 
many female specific topics, undoubtedly more high-qual-
ity research is warranted to overcome the heterogeneity and 
ambiguity seen in the limited number of studies in this area 
to date. Women account for half the world-wide population, 
therefore a willingness to study women as participants in 
sport and exercise science needs to be fostered and funding 
needs to be made available to achieve equivalence in knowl-
edge about the female sex.
3.4  Limitations of the Statement
Although this paper has covered many aspects of the repro-
ductive ageing female (i.e., from puberty to the menopause), 
it has not covered every perturbation of the menstrual cycle 
[75] or every type of hormonal contraceptive [76] or all 
aspects of (post) menopausal hormonal therapy. In addition, 
medications known to influence the hypothalamic-pituitary-
ovarian axis are beyond the scope of this statement [77].
4  Conclusions
In order to improve the quality of future research in sport and 
exercise science with women as participants, more research-
ers need to accept the challenges of working in this area and 
embrace the means and mechanisms to produce high quality 
scientific studies on essentially half the world’s population. 
The considerations presented in this paper are not intended 
to be the panacea for studies on sportswomen; instead they 
are intended to guide readers to adopt good practice in this 
area and prompt further consideration of the issues involved 
in women-based sport and exercise science studies. As every 
woman’s menstrual cycle is different and can change across 
the lifespan, there might never be a universal blueprint that 
research studies and practitioners can exclusively use to 
direct training and performance; however, if we understand 
and appreciate how ovarian hormones affect different physi-
ological systems, we can use this knowledge to tailor exer-
cise programmes for women in response to the reproductive 
events throughout their lifespan.
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